W
William Arcese
Researcher at University of Rome Tor Vergata
Publications - 204
Citations - 7756
William Arcese is an academic researcher from University of Rome Tor Vergata. The author has contributed to research in topics: Transplantation & Acute leukemia. The author has an hindex of 37, co-authored 204 publications receiving 6961 citations.
Papers
More filters
Journal ArticleDOI
Transplants of Umbilical-Cord Blood or Bone Marrow from Unrelated Donors in Adults with Acute Leukemia
Vanderson Rocha,Myriam Labopin,Guillermo Sanz,William Arcese,Rainer Schwerdtfeger,Alberto Bosi,Niels Jacobsen,Tapani Ruutu,Marcos de Lima,Jürgen Finke,Francesco Frassoni,Eliane Gluckman +11 more
TL;DR: Cord blood from an unrelated donor is an alternative source of hematopoietic stem cells for adults with acute leukemia who lack an HLA-matched bone marrow donor.
Journal ArticleDOI
Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis
Mary Eapen,Vanderson Rocha,Guillermo Sanz,Andromachi Scaradavou,Mei-Jie Zhang,William Arcese,Anne Sirvent,Richard E. Champlin,Nelson J. Chao,Adrian P. Gee,Luis Isola,Mary J. Laughlin,David I. Marks,Samir Kanaan Nabhan,Annalisa Ruggeri,Robert J. Soiffer,Mary M. Horowitz,Eliane Gluckman,John E. Wagner +18 more
TL;DR: These data support the use of UCB for adults with acute leukaemia when there is no HLA-matched unrelated adult donor available, and when a transplant is needed urgently.
Journal ArticleDOI
Allogeneic Stem Cell Transplantation for Agnogenic Myeloid Metaplasia: A European Group for Blood and Marrow Transplantation, Société Française de Greffe de Moelle, Gruppo Italiano per il Trapianto del Midollo Osseo, and Fred Hutchinson Cancer Research Center Collaborative Study
Philippe Guardiola,J E Anderson,Giuseppe Bandini,Francisco Cervantes,Volker Runde,William Arcese,Almalina Bacigalupo,Donna Przepiorka,Margaret R. O'Donnell,Paola Polchi,Agnès Buzyn,Laurent Sutton,Dominique Cazals-Hatem,George E. Sale,T. de Witte,Deeg Hj,Eliane Gluckman +16 more
TL;DR: Allogeneic stem cell transplantation is an effective treatment leading to cure in a substantial number of patients with AMM and a better characterization of the variables affecting the posttransplant outcome should lead to a decreased transplant-related mortality and an improvement in results.
Journal ArticleDOI
Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients
Almalina Bacigalupo,Benedetto Bruno,Paola Saracco,E. Di Bona,Anna Locasciulli,Francesco Locatelli,A. Gabbas,Carlo Dufour,William Arcese,G. Testi,G. Broccia,M. Carotenuto,P. Coser,Tiziano Barbui,P. Leoni,A. Ferster +15 more
TL;DR: A high probability for SAA patients of becoming transfusion independent and of surviving after treatment with ALG, CyA, 6Mpred, and G-CSF is confirmed, with a significant effect of neutrophil counts on outcome.
Journal ArticleDOI
Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone : a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation
M T Van Lint,Cornelio Uderzo,Anna Locasciulli,Ignazio Majolino,R Scimè,Francesco Locatelli,Giovanna Giorgiani,William Arcese,A. P. Iori,Michele Falda,Alberto Bosi,Roberto Miniero,Paolo Emilio Alessandrino,Giorgio Dini,Bruno Rotoli,Almalina Bacigalupo +15 more
TL;DR: Early treatment of acute GvHD with 6MPred 10 mg/ kg/d does not improve the response rate as compared with 2 mg/kg/d, nor does it prevent evolution to aGvHD grade III-IV, and CMV infections, TRM, and survival were comparable.